LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling ; volume:38 ; number:1 ; day:13 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (13.2.2019), 1-12, 12.2019
- Urheber
-
Xie, Zhi-Bo
Zhang, Yi-Fan
Jin, Chen
Mao, Yi-Shen
Fu, De-Liang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1088-0
- URN
-
urn:nbn:de:101:1-2019031600371620732338
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xie, Zhi-Bo
- Zhang, Yi-Fan
- Jin, Chen
- Mao, Yi-Shen
- Fu, De-Liang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of p38 MAP kinase in cancer stem cells and metastasis
Epigenetic control of pancreatic cancer metastasis
Engrailed‐1 Promotes Pancreatic Cancer Metastasis
Cystic gastric metastasis from pancreatic cancer
Synchronous intracellular delivery of EGFR-targeted antibody–drug conjugates by p38-mediated non-canonical endocytosis
Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Thoracic wall muscle metastasis from pancreatic cancer
The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway
Mechanisms of invasion and metastasis in pancreatic cancer
Molecular mediators of peritoneal metastasis in pancreatic cancer
Role of p38 MAP kinase in cancer stem cells and metastasis
Epigenetic control of pancreatic cancer metastasis
Engrailed‐1 Promotes Pancreatic Cancer Metastasis
Cystic gastric metastasis from pancreatic cancer
Synchronous intracellular delivery of EGFR-targeted antibody–drug conjugates by p38-mediated non-canonical endocytosis
Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Thoracic wall muscle metastasis from pancreatic cancer
The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway
Mechanisms of invasion and metastasis in pancreatic cancer
Molecular mediators of peritoneal metastasis in pancreatic cancer
Role of p38 MAP kinase in cancer stem cells and metastasis
Epigenetic control of pancreatic cancer metastasis
Engrailed‐1 Promotes Pancreatic Cancer Metastasis
Cystic gastric metastasis from pancreatic cancer
Synchronous intracellular delivery of EGFR-targeted antibody–drug conjugates by p38-mediated non-canonical endocytosis
Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism
Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC
Thoracic wall muscle metastasis from pancreatic cancer
The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway
Mechanisms of invasion and metastasis in pancreatic cancer